Comparison of Infection and Urosepsis Rates of Ciprofloxacin and Ceftriaxone Prophylaxis before Percutaneous Nephrolithotomy: A Prospective and Randomised Study

Table 1

Number of SIRS cases among antibiotic groups.

	Ciprofloxacin (CIPRO)				Ceftriaxone (CTX)
	1st Group	2nd Group	3rd Group	Total (N)	1st Group	2nd Group	3rd Group	Total (N)
SIRS (+)	1 (2.2%)	2 (4.4%)	4 (8.8%)	7 (15.5%)	2 (4.4%)	—	2 (4.4%)	4 (8.8%)
SIRS (−)	14 (31.1%)	13 (28.8%)	11 (24.4%)	38 (84.4%)	13 (28.8%)	15 (33.3%)	13 (28.8%)	41 (91.1%)
Total (N)	15 (33.3%)	15 (33.3%)	15 (33.3%)	45 (100%)	15 (33.3%)	15 (33.3%)	15 (33.3%)	45 (100%)

*No significant difference between ciprofloxacin and ceftriaxone in terms of SIRS (P = 0.52).
**No statistically significant difference between subgroups of both antibiotics in terms of SIRS positivity (CIP P = 0.306, CTX P = 0.334).
*** No significant difference between short- and long-term groups of both ciprofloxacin and ceftriaxone in terms of SIRS (CIP P = 0.19, CTX P = 0.59).
****Chi-Square test.